文献速递其他结缔组织病

新型Rpp38(Th/To)衍生B细胞表位自身抗体对系统性硬化症具有特异性并与独特临床表型相关

Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究通过血清池筛选Rpp25、Rpp38和hPop1的B细胞表位,合成肽段并以化学发光免疫分析法检测202例SSc患者和159例对照。发现Rpp38肽段(aa 229-243)自身抗体见于8/149(5.4%)局限型皮肤SSc患者,对照组均阴性(P=0.003)。该新型表位有望提高抗Th/To自身抗体检测敏感性。

要点

  • Rpp38肽段(aa 229-243)自身抗体在局限型皮肤SSc中检出率为5.4%,对照组为0%。
  • 该抗体与Rpp25结合相关(rho=0.44;P<0.0001),但部分血清仅对Rpp25或仅对新Rpp38肽段反应。
  • 新型Rpp38表位有望提高抗Th/To自身抗体检测敏感性,辅助SSc血清学诊断。

核心结论

  • 新型Rpp38表位有望提高抗Th/To自身抗体检测敏感性,从而增强SSc的血清学诊断。

研究设计与样本

  • 研究用含和不含抗Th/To自身抗体的血清池筛选Rpp25、Rpp38和hPop1的B细胞表位,合成生物素化可溶性肽段,以化学发光免疫分析法检测202例SSc患者和159例对照。

主要发现

  • 在三种蛋白上发现多个免疫优势区,其中Rpp38肽段(aa 229-243)反应最强。
  • Rpp38肽段自身抗体见于8/149(5.4%)局限型皮肤SSc患者,159例对照均未检出(双侧Fisher精确概率检验P=0.003)。
  • 对新抗原肽段的反应性与Rpp25结合相关(rho=0.44;P<0.0001),但部分患者血清仅强反应于Rpp25或仅强反应于新型Rpp38衍生肽段。

关键数值与推荐

  • Rpp38肽段(aa 229-243)自身抗体在局限型皮肤SSc患者中检出率为8/149(5.4%),对照组为0/159(P=0.003)。
  • Rpp38肽段反应性与Rpp25结合的相关性为rho=0.44(P<0.0001)。

临床怎么用

  • 检测新型Rpp38肽段(aa 229-243)自身抗体可能提高抗Th/To自身抗体检测敏感性,辅助SSc血清学诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Detection of antinuclear antibodies and specific autoantibodies is important in the diagnosis and classification of SSc. Several proteins of the Th/To complex, including Rpp25, Rpp38 and hPop1 are the target of autoantibodies in SSc patients. However, very little is known about the epitope distribution of this autoantigen. Consequently, we screened Rpp25, Rpp38 and hPop1 for B cell epitopes and evaluated their clinical relevance. METHODS: Serum pools with (n = 2) and without (n = 1) anti-Th/To autoantibodies were generated and used for epitope discovery. Identified biomarker candidate sequences were then utilized to synthesize synthetic, biotinylated, soluble peptides. The peptides were tested to determine reactivity with sera from SSc cohorts (n = 202) and controls (n = 159) using a chemiluminescence immunoassay. Additionally, samples were also tested for antibodies to full-length recombinant Rpp25 antibodies by chemiluminescence immunoassay. RESULTS: Several immunodominant regions were found on the three proteins. The strongest reactivity was observed with an Rpp38 peptide (aa 229-243). Autoantibodies to the Rpp38 peptide were detected in 8/149 (5.4%) limited cutaneous SSc patients, but not in any of 159 controls (P = 0.003 by two-sided Fisher's exact probability test). Although reactivity to the novel antigenic peptide was correlated with the binding to Rpp25 (rho = 0.44; P < 0.0001), subsets of patient sera either reacted strongly with Rpp25 or with the novel Rpp38-derived peptide. CONCLUSION: A novel Rpp38 epitope holds promise to increase the sensitivity in the detection of anti-Th/To autoantibodies, thus enhancing the serological diagnosis of SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Koenig M, Bentow C, Satoh M, et al. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype. Rheumatology (Oxford). 2019. PMID: 31323671. doi:10.1093/rheumatology/kez123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。